Amarin(us:AMRN)

    0.4567

    +2.95%

    Updated on 2024-12-25

    Open:0.4500
    Close:0.4567
    High:0.4600
    Low:0.4400
    Pre Close:0.4436
    Volume:1.26M
    Amount:563737.00
    Turnover:0.31%
    Shares:411.34M
    MarketCap:187.86M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-301837775058118.91%142864
    2024-03-311908832927721.50%184159
    2023-12-312029386569622.96%203869
    2023-09-302069019008922.08%114764
    2023-06-3021810300242425.24%164368
    2023-03-3122711354506227.88%264772
    2022-12-3122811595456528.68%314074
    2022-09-3024012899412631.94%183497
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Sarissa Capital Management Lp248506236.05%0
    2024-03-31Kynam Capital Management, Lp120229572.93%0
    2024-03-31Dg Capital Management, Llc64447431.57%103930519.23%
    2024-03-31Eversept Partners, Lp62127481.51%1172431.92%
    2024-03-31Morgan Stanley36103150.88%-1952768-35.10%
    2024-03-31Two Sigma Investments, Lp33943770.83%2100846.60%
    2024-03-31Two Sigma Advisers, Lp28123000.68%846983.10%
    2024-03-31Scp Investment, Lp25000000.61%0
    2024-03-31Tang Capital Management Llc25000000.61%-586544-19.00%
    2024-03-31Price Jennifer C.23800000.58%0

    About

    Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
    Address:Iconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green

    Market Movers